4//SEC Filing
Agarwal Vineet 4
Accession 0000950170-24-125822
CIK 0001703647other
Filed
Nov 11, 7:00 PM ET
Accepted
Nov 12, 7:40 PM ET
Size
22.3 KB
Accession
0000950170-24-125822
Insider Transaction Report
Form 4
Korro Bio, Inc.KRRO
Agarwal Vineet
Chief Financial Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2024-11-11−800→ 30,807 totalExercise: $11.68Exp: 2031-05-29→ Common Stock (800 underlying) - Sale
Common Stock
2024-11-11$70.00/sh−800$56,000→ 0 total - Exercise/Conversion
Common Stock
2024-11-11$11.68/sh+800$9,344→ 800 total
Footnotes (2)
- [F1]The reported transactions occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 19, 2024.
- [F2]The shares subject to the option vest as to 25% of the shares on May 11, 2022, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
Documents
Issuer
Korro Bio, Inc.
CIK 0001703647
Entity typeother
Related Parties
1- filerCIK 0001997973
Filing Metadata
- Form type
- 4
- Filed
- Nov 11, 7:00 PM ET
- Accepted
- Nov 12, 7:40 PM ET
- Size
- 22.3 KB